Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Phase 1

Recruiting

Conditions: Relapse
Resistant Cancer
Pancreas Cancer

Interventions: Biological: iC9-CAR.B7-H3 T cell infusion

First Posted Date: 2023-12-06

Last Posted Date: 2025-03-18

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 27

Registration Number: NCT06158139

Locations: 🇺🇸
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

Not Applicable

Recruiting

Conditions: Breast Cancer
Colorectal Cancer
Cancer

First Posted Date: 2023-10-24

Last Posted Date: 2025-01-30

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 240

Registration Number: NCT06096623

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Phase 1

Recruiting

Conditions: Recurrent
Refractory Cancer
Head and Neck Cancer
Relapse

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Biological: Cell Therapy

First Posted Date: 2023-10-23

Last Posted Date: 2025-01-27

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 33

Registration Number: NCT06096038

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States

ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

Phase 1

Recruiting

Conditions: Hodgkin Lymphoma
Relapse
Refractory

Interventions: Drug: Chemotherapy
Biological: Cell infusion

First Posted Date: 2023-10-19

Last Posted Date: 2025-02-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 31

Registration Number: NCT06090864

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

GRID Therapy for Extremity Soft Tissue Sarcoma

Not Applicable

Recruiting

Conditions: Sarcoma

First Posted Date: 2023-10-10

Last Posted Date: 2025-03-17

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT06073067

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

Not Applicable

Active, not recruiting

Conditions: Thoracic

First Posted Date: 2023-10-10

Last Posted Date: 2025-06-19

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 200

Registration Number: NCT06075316

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts

Not Applicable

Not yet recruiting

Conditions: Cognitive Symptom
Cognitive Burden

First Posted Date: 2023-09-06

Last Posted Date: 2025-04-22

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT06026098

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Impact of E-Cigarette Prevention Messages on Adolescents

Not Applicable

Completed

Conditions: Vaping Behavior

First Posted Date: 2023-08-14

Last Posted Date: 2025-01-16

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 480

Registration Number: NCT05985538

Locations: 🇺🇸
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Brain Slice Explants to Predict Drug Response in Brain Tumors

Recruiting

Conditions: Central Nervous System Tumor

First Posted Date: 2023-08-07

Last Posted Date: 2024-08-20

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 50

Registration Number: NCT05978557

Locations: 🇺🇸
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Physical Therapy in Pre-cystectomy Patients

Not Applicable

Completed

Conditions: Bladder Cancer

First Posted Date: 2023-08-07

Last Posted Date: 2025-03-04

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 68

Registration Number: NCT05978570

Locations: 🇺🇸
Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy